Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

INVESCO Ltd (NY:IVZ)

32.02 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Aug 21, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about INVESCO Ltd

< Previous 1 2 3 4 5 6 7 8 9
...
84 85 Next >
News headline image
FHLC vs. PJP: Which Healthcare ETF Is the Better Buy for Investors? ↗
Here's how Invesco's concentrated pharma play compares to Fidelity's diversified approach to healthcare stocks. 
Via The Motley Fool
Topics ETFs
News headline image
Institutional Investors Are Buying Hyperliquid Strategies. Should You? ↗
There's a lot more to their purchasing than a desire to own Hyperliquid itself. 
Via The Motley Fool
News headline image
Which Consumer Staples ETF Is a Better Buy: Invesco's RSPS or SPDR's XLP? ↗
State Street's market-cap approach delivered 22% stronger 5-year gains, but Invesco's equal-weight strategy offers more balanced exposure. 
Via The Motley Fool
Topics ETFs
Invesco (NYSE:IVZ) Passes Minervini Trend Template and High Growth Momentum Screen ↗
Via Chartmill
News headline image
The Smartest ETF to Buy With $750 Right Now ↗
The Invesco QQQ Trust has been a high-performing fund over the years. 
Via The Motley Fool
Topics Artificial Intelligence ETFs
News headline image
Which Biotech ETF Is a Better Buy: Concentrated Bet or Broad Basket? ↗
VanEck's concentrated 25-stock approach offers higher individual company exposure, while Invesco's broader 251-position portfolio delivered 47.4% returns over the past year. 
Via The Motley Fool
Topics ETFs
News headline image
Which Aerospace & Defense ETF Is a Better Buy: Big Bets or Broad Exposure? ↗
ITA boasts lower costs and stronger 1-year returns, while PPA delivers broader diversification and superior 5-year growth. 
Via The Motley Fool
Topics ETFs
News headline image
Pharma ETF or Biotech ETF: Which Matches Your Investing Mindset? ↗
IHE delivered 53.2% returns over one year with lower volatility and a 0.37% expense ratio, while PBE's quantitative biotech strategy carries higher risk. 
Via The Motley Fool
Topics ETFs
News headline image
IBBQ vs. PBE: Which Biotech ETF Is the Better Buy? ↗
PBE concentrates on 31 companies and offers a higher dividend yield, while IBBQ spreads risk across 251 holdings at a fraction of the cost. 
Via The Motley Fool
Topics ETFs
News headline image
Got $100? 1 Artificial Intelligence (AI) Memory ETF to Buy Hand Over Fist ↗
There's a major ETF focused on AI memory stocks, but it has some drawbacks. 
Via The Motley Fool
Topics Artificial Intelligence ETFs
News headline image
If We're in an AI Bubble, History Says This Is the Best Way to Recession-Proof Your Portfolio ↗
There might not be a safe place to hide in case of an AI bubble. But some ETFs could be less unsafe than others. 
Via The Motley Fool
Topics Artificial Intelligence ETFs Economy
News headline image
Prediction: This ETF Could Set You Up for Life if You Buy It Today ↗
This ETF blows away the Vanguard S&P 500 ETF. 
Via The Motley Fool
Topics ETFs Retirement Stocks
News headline image
Invesco Nasdaq Biotech vs. Invesco Pharma: How Do These ETFs Stack Up? ↗
One offers concentrated exposure to 29 pharma giants with lower volatility, while the other provides broader diversification across 251 biotech companies at a cheaper cost. 
Via The Motley Fool
Topics ETFs
News headline image
XOP vs TAN: Will an Oil & Gas ETF Bring More Profits Than a Solar Fund in 2026? ↗
XOP's 0.35% expense ratio and lower volatility appeal to conservative investors, while TAN's 1.41 beta offers higher conviction exposure to renewable energy. 
Via The Motley Fool
Topics ETFs
News headline image
Caterpillar Costs the Dow 255 Points and Most Stocks Barely Notice ↗
Caterpillar alone stripped 255 points off the Dow. Most other stocks had a perfectly ordinary day. 
Via The Motley Fool
Topics ETFs Government Stocks
News headline image
PBJ vs. XLP: Which Consumer Staples ETF Is the Better Bet? ↗
XLP's lower fees and higher dividend yield have driven superior five-year returns, but PBJ offers concentrated food-and-beverage exposure for tactical investors. 
Via The Motley Fool
Topics ETFs
News headline image
Commodities Are Booming, But These 3 ETFs Tell Different Stories ↗
Commodity ETFs BCI, PDBC, and COM have posted strong 2026 gains amid inflation and geopolitical pressures, though returns, fees, and yields vary widely across each fund's strategy. 
Via MarketBeat
Topics Artificial Intelligence ETFs Economy
News headline image
XPH vs PJP: Which Pharma ETF Offers Better Value ↗
State Street's lower costs appeal to buy-and-hold investors, while Invesco's concentrated portfolio and lower volatility suit risk-averse income seekers. 
Via The Motley Fool
Topics ETFs
News headline image
Prediction: If a Bear Market Is Coming, This ETF Will Be the Biggest Long-Term Winner ↗
It's hard to go wrong with the Vanguard S&P 500 ETF. 
Via The Motley Fool
Topics ETFs Stocks
News headline image
History Shows Right Now Could Be a Fantastic Time to Invest in the Stock Market. Here's Why. ↗
It's a midterm election year, and that could be good news for investors willing to take the long view with these ETFs. 
Via The Motley Fool
Topics ETFs
News headline image
History Says a $10,000 Investment in the QQQ Will Be Worth $66,000 in 10 Years ↗
Investors that bought this booming exchange-traded fund a decade ago and held on have benefited from the success of the technology sector. 
Via The Motley Fool
Topics Artificial Intelligence ETFs
News headline image
The Vanguard S&P 500 ETF (VOO) Beat the Vanguard Morningstar Total Stock Market ETF (VTI) for 4 Straight Years. Here's Why That's About to Change. ↗
The Vanguard Morningstar Total Stock Market ETF is more value-oriented and diversified than the Vanguard S&P 500 ETF. 
Via The Motley Fool
Topics ETFs Stocks
News headline image
If You Invest $100 a Month in VGT Starting Today, Here's What History Says You Could Have in 20 Years ↗
You wonʻt believe how much a $5,000 investment in the Vanguard Information Technology ETF would have generated over the past 20 years. 
Via The Motley Fool
Topics ETFs Retirement
News headline image
The L.A. Lakers Delivered a 1-Year Return of 25%. These ETFs Have Done Even Better. ↗
Most people don't have $12.5 billion to buy the L.A. Lakers. But with stock ETFs, you could earn a higher return than the Lakers' owners. 
Via The Motley Fool
Topics Artificial Intelligence ETFs Economy
News headline image
Which Is the Better ETF, State Street's Broad Market Exposure Through SPY or Invesco's Tech-Focused QQQ? ↗
QQQ delivered higher returns while SPY sports lower fees and a higher dividend yield. 
Via The Motley Fool
Topics ETFs
News headline image
Which Small-Cap ETF Is the Better Buy: iShares' Growth-Focused IWO or Invesco's Revenue-Weighted RWJ? ↗
Small-cap stocks are surging, but how you own them matters more than most investors realize. 
Via The Motley Fool
Topics ETFs
News headline image
This Healthcare ETF Is Outperforming the Invesco Equal Weight Fund -- and It Offers a Charitable Twist ↗
Active management and concentrated bets drove a 42% one-year return, though the lower-cost Invesco alternative offers broader diversification across 60 healthcare stocks. 
Via The Motley Fool
Topics ETFs
News headline image
Which Is the Better Invesco Healthcare ETF: Equal-Weight RSPH or Biotech-Focused IBBQ? ↗
RSPH levels the playing field across 60 established healthcare names while IBBQ bets on more than 250 biotech companies at a lower cost. 
Via The Motley Fool
Topics ETFs
News headline image
Better Healthcare ETF: State Street's Pharmaceuticals-Focused XPH vs. Invesco's S&P 500-Targeted RSPH ↗
One fund targets pharma exclusively and surged 63% in a year, while the other diversifies across healthcare with lower volatility. 
Via The Motley Fool
Topics ETFs Stocks
News headline image
VanEck Pharmaceutical ETF vs. Invesco Biotech ETF: Which Fund Fits Your Investing Style? ↗
VanEck targets established pharma giants with lower costs and volatility, while Invesco pursues high-growth biotech companies. One delivered stronger returns; the other weathered downturns better. 
Via The Motley Fool
Topics ETFs
< Previous 1 2 3 4 5 6 7 8 9
...
84 85 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.